
Coronavirus Vaccine U.K. Trial Restarts, but Scientists Question Lack of Transparency
U.K. trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been released

Coronavirus Vaccine U.K. Trial Restarts, but Scientists Question Lack of Transparency
U.K. trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been released

Scientists React​ to Halt of Leading Coronavirus Vaccine Trial
Scientists urge caution in the global vaccine race as AstraZeneca reports an “adverse event” in a person who received the University of Oxford vaccine


Costa Rica Readies Horse Antibodies for Trials as an Inexpensive COVID-19 Therapy
After neutralizing SARS-CoV-2 in cell culture, scientists at the University of Costa Rica are proceeding with human testing

‘Warp Speed’ COVID-19 Vaccine Efforts Aim for Diverse Volunteers and Long-Lasting Protection
The Trump administration’s Operation Warp Speed program is backing six efforts with the ambitious goal of delivering an effective vaccine by January

How to Decide Who Should Get a COVID-19 Vaccine First
Medical ethicist Ezekiel Emanuel discusses a framework for equitably allocating COVID-19 vaccines based on preventing premature deaths and mitigating long-term economic impacts

In the Fight against Infectious Disease, Social Changes Are the New Medicine
Vaccines and drugs drove a century of progress, but today’s contagions thrive on inequality

Evidence for Convalescent Plasma Coronavirus Treatment Lags behind Excitement
Despite calls for more rigorous clinical trials, the Food and Drug Administration has granted an emergency authorization for the therapy

Thousands Volunteer for COVID-19 Vaccine Study
Late-stage clinical trials of the first two coronavirus vaccine candidates in the U.S. plan to recruit 60,000 Americans

Fluoridated Water Criticized as Socialized Medicine
Originally published in February 1955

Pill Takes the Bite Out of Viper Venom
A preexisting drug could buy time for snakebite treatment

Fauci Optimistic About COVID-19 Vaccines, Though Immunity Unknowns Complicate Development
Teams are starting to test vaccines using messenger RNA or chimpanzee cold viruses to inoculate humans. Will their benefits last?

Concerns about Waning COVID-19 Immunity Are Likely Overblown
The decline seen in some studies is normal, experts say. But scientists must wait to see whether infection confers long-term protection